Kristina Krpina1, Miroslav Samarzija1,2 and Lara Baticic3*
1Clinic for Respiratory Diseases Jordanovac, University Hospital Centre Zagreb, Croatia
2Faculty of Medicine, University of Zagreb, Croatia
3Department of Medical Chemistry, Biochemistry and Clinical Chemistry, Faculty of Medicine, University of Rijeka, Croatia
*Corresponding Author: Lara Baticic, Department of Medical Chemistry, Biochemistry and Clinical Chemistry, Faculty of Medicine, University of Rijeka, Croatia.
Received: November 17, 2022; Published: January 09, 2023
Cancer is one of the most frequently diagnosed diseases with increasing incidence worldwide. The treatment of cancer requires a multidisciplinary methodology due to the complexity of the disease, the therapeutic possibilities of personalized medicine and the peculiarities of carcinogenesis, which is essential for the selection of an appropriate therapy . Extensive evidence has been published on the molecular background of cancer development and progression, which can help tailor therapy to individual patients and improve their survival prognosis. Drug-specific therapeutic methodologies for cancer have contributed to substantial enhancements in overall survival and general quality of life for patients. However, there remains a pronounced need to expand personalization of treatments based on genetic and epigenetic tumor profiles in order to maximize quality and efficiency while limiting cytotoxicity of the oncological treatment. Early detection, accurate diagnosis, and treatment monitoring of cancer with specific markers and targeted molecular testing can be of great benefit to cancer patients .
Citation: Lara Baticic., et al. “New Biomarkers in Oncology in the COVID-19 Era”.Acta Scientific Medical Sciences 7.2 (2023): 44-46.
Copyright: © 2022 Lara Baticic., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.